Response to Kim et al. re: "Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19"

被引：6
|
作者：
Sengupta, Vikram [1 ,2 ]
Sengupta, Sascha [2 ,3 ]
Lazo, Angel, Jr. [4 ]
Hicok, Kevin C. [5 ]
Moseley, Timothy [5 ]
机构：
[1] NYU, Grossman Sch Med, Dept Internal Med, 550 1st Ave, New York, NY 10016 USA
[2] Thrivewell Infus LLC, Brooklyn, NY USA
[3] Mt Sinai Hosp Brooklyn, Dept Anesthesiol, Brooklyn, NY USA
[4] Englewood Hosp, Dept Internal Med, Englewood, NJ USA
[5] Direct Biol LLC, Dept Res & Dev, Austin, TX USA
来源：
STEM CELLS AND DEVELOPMENT | 2020年 / 29卷 / 14期
关键词：
D O I：
10.1089/scd.2020.0095
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
引用
收藏
页码：879 / 881
页数：3
相关论文
共 50 条
  • [1] Re: "Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19" by Sengupta et al.
    Lim, Sai Kiang
    Giebel, Bernd
    Weiss, Daniel J.
    Witwer, Kenneth W.
    Rohde, Eva
    STEM CELLS AND DEVELOPMENT, 2020, 29 (14) : 877 - 878
  • [2] Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19
    Sengupta, Vikram
    Sengupta, Sascha
    Lazo, Angel, Jr.
    Woods, Peter
    Nolan, Anna
    Bremer, Nicholas
    STEM CELLS AND DEVELOPMENT, 2020, 29 (12) : 747 - 754
  • [3] Mesenchymal stem cells and their derived exosomes for the treatment of COVID-19
    Hou, Xiang-Yi
    Danzeng, La-Mu
    Wu, Yi-Lin
    Ma, Qian-Hui
    Yu, Zheng
    Li, Mei-Ying
    Li, Li-Sha
    WORLD JOURNAL OF STEM CELLS, 2024, 16 (04):
  • [4] Mesenchymal stem cells and their derived exosomes to combat Covid-19
    Yousefi Dehbidi, Maryam
    Goodarzi, Nima
    Azhdari, Mohammad H.
    Doroudian, Mohammad
    REVIEWS IN MEDICAL VIROLOGY, 2022, 32 (02)
  • [5] Treatment of COVID-19 Patients: Insights into the Use of Bone Marrow-Derived Mesenchymal Stem Cells
    Andrade, Heitor Duarte
    Kondo, Andrea Tiemi
    Kerbauy, Lucila
    Alves Paiva, Raquel de Melo
    Oliveira, Denise Cristine
    Coa, Larissa Leggieri
    Arcuri Alvarez, Kelen Cristina
    Savioli, Mariana Lorenzi
    Coelho Loureiro, Bruna Melo
    Okamoto, Oswaldo Keith
    Hamerschlak, Nelson
    Kutner, Jose Mauro
    Preto Godoy, Juliana Aparecida
    BLOOD, 2021, 138
  • [6] Immunomodulatory effect of mesenchymal stem cells and mesenchymal stem-cell-derived exosomes for COVID-19 treatment
    Jayaramayya, Kaavya
    Mahalaxmi, Iyer
    Subramaniam, Mohana Devi
    Raj, Neethu
    Dayem, Ahmed Abdal
    Lim, Kyung Min
    Kim, Se Jong
    An, Jong Yub
    Lee, Yoonjoo
    Choi, Yujin
    Raj, Arthi
    Cho, Ssang-Goo
    Vellingiri, Balachandar
    BMB REPORTS, 2020, 53 (08) : 400 - 412
  • [7] Mesenchymal stem cells in the treatment of severe COVID-19
    Santosh Kesari
    Gregory C. Kasper
    Lev Verkh
    Terese C. Hammond
    Marla L. Matal
    Jay W. Hammerling
    Nikolai Tankovich
    Adrianus P. Lim
    Kevin H. Zhao
    Tiffany Juarez
    Roberta E. Redfern
    Jaya M. Gill
    Natsuko Nomura
    Audrey Hiemer
    Annie Heng
    Jessica Shoemaker
    Translational Medicine Communications, 6 (1)
  • [8] Re: Remdesivir for the treatment of COVID-19 by Lee et al.
    Beccacece, Alessia
    Bartoli, Tommaso Ascoli
    Nicastri, Emanuele
    CLINICAL MICROBIOLOGY AND INFECTION, 2023, 29 (01) : 114 - 114
  • [9] Potential roles of mesenchymal stem cells and their exosomes in the treatment of COVID-19
    Cheng, Xiaoyun
    Jiang, Mao
    Long, Lingzhi
    Meng, Jie
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2021, 26 (10): : 948 - 961
  • [10] Correction to: Mesenchymal stem cells in the treatment of severe COVID-19
    Santosh Kesari
    Gregory C. Kasper
    Lev Verkh
    Terese C. Hammond
    Marla L. Matal
    Jay W. Hammerling
    Nikolai Tankovich
    Adrianus P. Lim
    Kevin H. Zhao
    Tiffany Juarez
    Roberta E. Redfern
    Jaya M. Gill
    Natsuko Nomura
    Audrey Hiemer
    Annie Heng
    Jessica Shoemaker
    Translational Medicine Communications, 6 (1)
12345